Teva Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Teva Pharmaceuticals

TEVA 36.23

+1.9%

Feb 3 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: jay silberman who wrote (123)	11/14/1997 12:43:00 AM
From: Gary105	Read Replies (1) of 340

Page 36 of Decembers Individual Investor (just out) quotes 2 analysts: Saks of Gruntal looks for $2.4 this yr and $3.75 next yr with target of $94 by end of next yr Buermann of Merrill has target of $67 (presumably for '98) - bullish but doesnt see it attaining same p/e of US drug makers. Article says Teva's R&D is subsidized (up to 50%) by Israeili govt (with payback if developed drugs are successful) and has strong collaboration with well known Weizmann Institute. Pipeline has drugs which target central nervous system and autoimmune disorders, including drugs for Alzheimers, Parkinsons and epilepsy. I like the collaboration with Weizmann - analogous to a U.S. company doing collaborative work with M.I.T - access to great brainpower at low cost and with govt subsidy. Gary

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next